Geode Capital Management, LLC Ventyx Biosciences, Inc. Transaction History

Geode Capital Management, LLC

$1.24 Trillion
Q1 2025

A detailed history of Geode Capital Management, LLC transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,463,103 shares of VTYX stock, worth $3.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,463,103

Previous 1,413,039 3.54%

Holding current value

$3.31 Million

Previous $3.09 Million 45.64%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$1.15 - $2.52 $57,573 - $126,161	50,064 Added 3.54%	1,463,103 $1.68 Million
Q4 2024 Feb 12, 2025	BUY	$1.72 - $3.12 $36,699 - $66,571	21,337 Added 1.53%	1,413,039 $3.09 Million
Q3 2024 Nov 12, 2024	BUY	$1.85 - $3.2 $143,097 - $247,520	77,350 Added 5.89%	1,391,702 $3.03 Million
Q2 2024 Aug 09, 2024	BUY	$2.31 - $5.59 $479,422 - $1.16 Million	207,542 Added 18.75%	1,314,352 $3.04 Million
Q1 2024 May 13, 2024	BUY	$1.9 - $10.13 $154,262 - $822,464	81,191 Added 7.92%	1,106,810 $6.09 Million
Q4 2023 Feb 13, 2024	BUY	$2.08 - $31.18 $103,602 - $1.55 Million	49,809 Added 5.1%	1,025,619 $2.53 Million
Q3 2023 Nov 13, 2023	BUY	$29.8 - $40.3 $5.96 Million - $8.06 Million	200,090 Added 25.79%	975,810 $33.9 Million
Q2 2023 Aug 11, 2023	BUY	$28.53 - $39.55 $6.81 Million - $9.44 Million	238,578 Added 44.42%	775,720 $25.4 Million
Q1 2023 May 15, 2023	BUY	$29.51 - $46.65 $818,253 - $1.29 Million	27,728 Added 5.44%	537,142 $18 Million
Q4 2022 Feb 13, 2023	BUY	$24.16 - $36.38 $2.43 Million - $3.65 Million	100,452 Added 24.56%	509,414 $16.7 Million
Q3 2022 Nov 14, 2022	BUY	$12.64 - $38.7 $1.55 Million - $4.75 Million	122,759 Added 42.89%	408,962 $14.3 Million
Q2 2022 Aug 12, 2022	BUY	$11.95 - $18.75 $1.08 Million - $1.7 Million	90,551 Added 46.28%	286,203 $3.5 Million
Q1 2022 May 13, 2022	BUY	$10.0 - $19.98 $81,130 - $162,097	8,113 Added 4.33%	195,652 $2.65 Million
Q4 2021 Feb 11, 2022	BUY	$14.2 - $23.07 $2.66 Million - $4.33 Million	187,539 New	187,539 $3.72 Million

Others Institutions Holding VTYX

# of Institutions

126

Shares Held

45.4M

Call Options Held

35.2K

Put Options Held

40.6K

View Full List

About Ventyx Biosciences, Inc.

Ticker VTYX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,527,200
Market Cap $128M
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...

More about VTYX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Ventyx Biosciences, Inc. Transaction History